Transabdominal Preperitoneal (TAPP) repair for a recurrent inguinal hernia
Official title: Clinical Outcomes of Laparoscopic Transabdominal Preperitoneal (TAPP) Approach for Recurrent Inguinal Hernia
Run by Sohag University · NCT07608653 · Data updated 2026-11-12
This study tests if laparoscopic TAPP repair safely fixes a recurrent groin hernia after prior surgery and helps patients recover well.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 10 (estimated) |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Status | Recruiting |
| Started | April 1, 2026 |
| Main results expected | July 1, 2026 |
| Study ends | July 1, 2026 |
| Registry record updated | June 1, 2026 |
| Trial ID | NCT07608653 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with a confirmed recurrent inguinal hernia who are fit for general anesthesia and provide informed consent.
✕Probably not a fit
Patients without benefit include those with non-recurrent hernias, complicated hernias, or those unfit for general anesthesia.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study examines whether the laparoscopic Transabdominal Preperitoneal repair can safely treat adults with recurrent inguinal hernias. Participants undergo the TAPP procedure and are monitored shortly after surgery with regular follow-ups to track long-term recovery and complications. The goal is to determine if using a different tissue layer provides a stronger, durable repair in the setting of scar tissue from prior operations. The study is conducted at Sohag University in the Faculty of Medicine, enrolling adults who are suitable for general anesthesia and provide informed consent. Outcomes focus on postoperative complications and recovery trajectories over time.
Why it matters
Potential benefit: If successful, patients may experience fewer complications and better, faster recovery after a recurrent hernia repair using TAPP.
How similar studies have gone: Previous laparoscopic approaches for recurrent hernias have shown promise, but this study adds data on TAPP performance in the scarred, recurrent setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients. Patients diagnosed with recurrent inguinal hernia. Patients fit for general anesthesia. Patients who provide informed consent. Exclusion Criteria: * Non recurrent inguinal hernia Patients with complicated inguinal hernia. Patients unfit for general anesthesia. Patients refusing participation in the study.
Where it's running
-
Faculty of medicine
Sohag, Egypt Recruiting
Study contacts
- Study coordinator: marwa Saber, Resident
- Email: marwaelkholy93@gmail.com
- Phone: 01017659722
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Trauma registry at Sohag University Hospital
This study tests the creation of a trauma registry in the emergency department to collect data on injured adults admitted with polytrauma at Sohag University Hospital.
-
Prevalence of Myocardial Bridging and its relation to Coronary Plaques on MDCT
This study tests how common myocardial bridging is and whether it relates to coronary plaque in patients undergoing coronary CT angiography.
-
Septoplasty: see if it changes headache symptoms
This study tests whether septoplasty can change headache severity in adults with septal deviation and headache.
-
Predicting SLE Flares with Patient Reports and Machine Learning
Aims to test a low-cost, patient-reported outcome–based machine learning tool to see if it can detect lupus flares early and support care, especially in settings with limited resources.
-
Is geographic mismatch linked to short-term major heart problems after long drug-eluting stent placement?
This study checks whether geographic mismatch can predict short-term major adverse cardiovascular events after a long drug-eluting stent is placed in the coronary arteries.
-
Biomarkers to predict no-reflow after opening the heart’s artery in STEMI patients
This study tests whether immune-inflammatory and metabolic biomarkers can predict coronary no-reflow after primary PCI in adults with STEMI.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.